Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib
Clinical trial NCT00802841 · COMPLETED
Trial details
- NCT number
- NCT00802841
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2014-07-01
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.